GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Elutia Inc.
Elutia is a company that produces biological medical devices for reconstructive surgery. Its stock price reflects the adoption of its products in surgical practice and its long history, which has included restructuring.
Share prices of companies in the market segment - Medical instruments
Elutia Inc. develops and manufactures biological implants and tissue regeneration materials used in surgery. We've classified it under "Medical Instruments." The chart below shows how investors value companies in the regenerative medicine sector.
Broad Market Index - GURU.Markets
Elutia Inc. develops and manufactures biological implants and tissue regeneration materials used in surgery. It is a component of the GURU.Markets index. The chart below represents the market. See how this stock compares to the medical technology sector.
Change in the price of a company, segment, and market as a whole per day
ELUT - Daily change in the company's share price Elutia Inc.
For Elutia Inc., a regenerative medicine company, daily volatility reflects sensitivity to sales of its biological implants. This metric is an indicator of demand for its products in surgical practice.
Daily change in the price of a set of shares in a market segment - Medical instruments
The medical instruments sector, in which Elutia Inc. operates, is highly dynamic. This chart reflects the industry's average volatility. It serves as a benchmark for assessing how sensitive Elutia's biomaterials development business is to general trends and clinical trial news.
Daily change in the price of a broad market stock, index - GURU.Markets
Elutia is a company specializing in the production of biomaterials for reconstructive surgery. This medtech company's stock reflects the demand for advanced medical solutions. Its price movement reflects the contribution of innovative medicine to overall market volatility.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Elutia Inc.
Elutia Inc.'s year-over-year performance tells the story of its performance in the biomedical market. Its 12-month market cap reflects demand for its animal tissue meshes for reconstructive surgery, as well as its success in developing a new drug delivery business, which is its bet for the future.
Annual dynamics of market capitalization of the market segment - Medical instruments
Elutia Inc. is a regenerative medicine company. Following its restructuring, its goal is to prove the sustainability of its business. The chart below shows how the market views its new, more focused strategy and its ability to commercialize its products in the medical device sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Elutia, a medical device manufacturer, operates in the protective sector. Demand for its products is driven by medical needs, not the state of the economy. The company's stock performance reflects its success in innovation and sales, making it a non-cyclical growth story, isolated from general market cycles.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Elutia Inc.
Elutia is a company that produces biological medical devices. Its monthly growth reflects the rate of adoption of its products by surgeons. Quarterly reports of revenue growth and the number of procedures performed are the main drivers of its value on its path to profitability.
Monthly dynamics of market capitalization of the market segment - Medical instruments
Elutia develops and manufactures biological implants and tissue regeneration devices used in surgery. The graph below illustrates the overall dynamics of the medical instrument sector, where innovative materials for tissue regeneration play a key role.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Elutia Inc. develops and manufactures biomaterials for regenerative medicine. The company operates at the intersection of biotech and medical devices. Its growth depends on the successful commercialization of its products and regulatory approvals, rather than on general economic cycles.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Elutia Inc.
Shares of Elutia, a biomedical device company, react weekly to news about the acceptance of its products by surgeons. Sales growth data and comparisons with competitors are key drivers of short-term performance.
Weekly dynamics of market capitalization of the market segment - Medical instruments
Elutia shares, like those of the entire medical technology sector, respond to general trends in healthcare. Surgical procedure volumes and hospital budgets are key drivers for everyone. The chart shows how this biomaterials-focused company stacks up against this backdrop.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Elutia shares, like those of the entire medical technology sector, respond to general trends in healthcare. Surgical procedure volumes and hospital budgets are key drivers for everyone. The chart shows how this biomaterials-focused company stacks up against this backdrop.
Market capitalization of the company, segment and market as a whole
ELUT - Market capitalization of the company Elutia Inc.
Elutia's market capitalization is the financial valuation of a company that produces biomedical devices based on regenerative technologies for implant fixation and drug delivery. The chart reflects the potential of its platform. Its dynamics tell the story of how investors assess its path to commercialization and widespread use in surgery.
ELUT - Share of the company's market capitalization Elutia Inc. within the market segment - Medical instruments
Elutia develops and manufactures biological medical devices to simplify complex surgical procedures. Its market share reflects its innovative approach to creating materials that work in harmony with the body. The chart below shows its market share in the regenerative medicine market.
Market capitalization of the market segment - Medical instruments
Elutia is a company developing regenerative biological products. The chart below shows the overall market capitalization of the medical instrument sector. Its growth reflects the search for new ways to repair tissue. Elutia is banking on its unique materials to improve surgical outcomes.
Market capitalization of all companies included in a broad market index - GURU.Markets
The medical implants visible in the graph use innovative materials. Elutia Inc. develops biological implants that are replaced over time by the body's own tissue. Its capitalization represents a risky bet on this regenerative medicine technology.
Book value capitalization of the company, segment and market as a whole
ELUT - Book value capitalization of the company Elutia Inc.
Elutia's chart represents the material base for the creation of bioresorbable medical devices. Its book value reflects the value of its manufacturing facilities, where unique meshes and drug carriers are created that are completely absorbed by the body over time.
ELUT - Share of the company's book capitalization Elutia Inc. within the market segment - Medical instruments
Elutia Inc. (formerly Aziyo Biologics) produces regenerative medical products. Its share of the sector's assets is its manufacturing facilities. This physical base allows it to create biopharmaceuticals for cardiac surgery and orthopedics from human and animal tissue.
Market segment balance sheet capitalization - Medical instruments
Elutia Inc. produces bio-implants. Its business is moderately capital-intensive. The company requires its own production facilities to create its products. Compared to the medical device sector, this demonstrates that the production of innovative materials requires control over physical assets.
Book value of all companies included in the broad market index - GURU.Markets
Elutia's assets are not drugs, but unique biomedical materials, such as a biological mesh for soft tissue reinforcement during surgery. The company's balance sheet reflects the value of its production capacity. The chart shows the capital behind the creation of these innovative medical devices.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Elutia Inc.
Elutia is a biomedical company. Its market capitalization is based on its patented products and their ability to improve treatment outcomes. Investors pay a premium for its innovations in regenerative medicine.
Market to book capitalization ratio in a market segment - Medical instruments
Elutia is a company that produces biomedical devices for surgical applications. Its value lies in its proprietary materials and products. This chart shows the premium the market pays for its innovation and its ability to compete with larger players in the medical device market.
Market to book capitalization ratio for the market as a whole
Elutia is a medical technology company developing biomaterials for surgical applications. Its valuation is based on its unique technology and patents. This chart demonstrates the high premium investors pay for innovative medical products offering superior clinical outcomes compared to the market average.
Debts of the company, segment and market as a whole
ELUT - Company debts Elutia Inc.
Elutia develops and manufactures biological medical devices. Growth in the medical technology market requires investment in clinical trials to prove efficacy, as well as marketing to promote the product to surgeons. Debt can help the company finance these commercial efforts.
Market segment debts - Medical instruments
Elutia Inc. produces biological medical devices for surgical applications. This sector requires investment in R&D, clinical data, and marketing to physicians. This chart shows how the company finances its operations and how its debt policy supports its efforts to advance its unique products in the competitive medical device market.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Elutia Inc.
Elutia Inc., formerly known as Aziyo Biologics, produces regenerative medical products. This chart shows its debt load. In the medical technology industry, where consistent clinical data and approvals are essential, high debt can be risky, especially if product sales don't meet projections.
Market segment debt to market segment book capitalization - Medical instruments
Elutia develops and manufactures biological surgical implants that are completely replaced by the body's own tissue over time. This chart compares the company's debt to the overall market capitalization of the entire medical devices sector. It helps assess how the company is financing the implementation of its innovative regenerative materials.
Debt to book value of all companies in the market
Elutia Inc. develops and manufactures surgical biomaterials. Commercializing medical devices requires investment in manufacturing, marketing, and clinical research. The chart shows how the company leverages its growth. Comparisons with the medical technology sector help evaluate the effectiveness of its business strategy.
P/E of the company, segment and market as a whole
P/E - Elutia Inc.
For Elutia, a biomedical device company, this chart is a valuation of its innovative products. The price-to-earnings ratio shows whether investors believe its tissue regeneration materials will be in demand by surgeons. The trend reflects sales growth and the acceptance of its technologies by the medical community.
P/E of the market segment - Medical instruments
This chart shows the average valuation for medical device manufacturers—the benchmark for Elutia. Comparing this metric helps investors understand how the market views the company's technology and its growth potential compared to competitors. A higher-than-average valuation may indicate confidence in the superiority of its biomaterials.
P/E of the market as a whole
Elutia develops and manufactures biological medical devices for soft tissue reconstruction using technology designed to promote the regeneration of a patient's own tissue. This chart reflects the state of the medical technology sector. It helps understand how the market views this advanced regenerative technology and its potential to improve surgical outcomes compared to existing materials.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Elutia Inc.
Elutia develops and manufactures biological materials for surgery, such as drug-carrying meshes. Future profits depend on the clinical adoption of its innovative products. This chart shows whether analysts believe the company's technology can capture a significant share of the medical device market.
%20P%2FE%20Elutia%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Elutia-Inc.&v=1772621346077 "Chart of the company's future (projected) P/E Elutia Inc.")
Future (projected) P/E of the market segment - Medical instruments
Elutia is a regenerative medicine company that produces biological implants that help the body regenerate its own tissue. This chart compares its future profitability expectations with those of the medical device industry. It helps understand how the market views its innovative products and their potential to replace synthetic materials in surgery.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Medical-instruments&v=1772621346157 "Future (projected) P/E graph of the market segment - Medical instruments")
Future (projected) P/E of the market as a whole
Elutia is a company that develops and manufactures biological medical devices for surgery. This chart reflects the overall sentiment in the healthcare sector. For ELUT, the focus isn't on economics, but on the acceptance of their products by surgeons. This is a growth story based on offering superior clinical solutions.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772621346189 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Elutia Inc.
Elutia is a company that develops and manufactures biological medical devices, such as animal-derived surgical meshes for reconstructive surgery. This chart shows financial results based on the acceptance of its products by surgeons and their effectiveness compared to synthetic alternatives.
Profit of companies in the market segment - Medical instruments
Elutia is a regenerative medicine company. It develops and manufactures biological implants that help the body repair damaged tissue. This chart shows the overall profitability of the medical devices sector, demonstrating how innovative biomaterials are changing surgical approaches and promoting healing.
Overall market profit
Elutia Inc. produces biomedical products such as surgical mesh. Demand for its products is determined by the number of surgical procedures and is not affected by economic cycles. This provides the company with stable revenue. Hospitals require its products constantly, making Elutia's business highly resilient during market volatility.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Elutia Inc.
Elutia is a company that develops and manufactures biological medical devices for regenerative medicine. Its products are used in surgery for tissue repair. This chart reflects analysts' expectations for growing demand for such innovative materials in medical practice.
%20profit%20of%20the%20company%20Elutia%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Elutia-Inc.&v=1772621346298 "Graph of future (projected) profit of the company Elutia Inc.")
Future (predicted) profit of companies in the market segment - Medical instruments
Elutia Inc. develops and manufactures biological products for complex surgical procedures, such as tissue regeneration matrices. This chart shows forecasts for the medical technology sector. Elutia's profitability depends on the acceptance of its products by surgeons, insurance reimbursement, and proof of the benefits of its healing and recovery solutions.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Medical-instruments&v=1772621346312 "Graph of future (predicted) profits of companies in a market segment - Medical instruments")
Future (predicted) profit of the market as a whole
Elutia Inc. develops and manufactures biomedical devices, particularly for surgical applications. Demand for its products depends on the number of elective surgeries and hospital budgets. This graph, which reflects corporate profit forecasts, is an indicator of the overall economic situation, which impacts healthcare funding and, consequently, medical device procurement.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772621346325 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Elutia Inc.
Elutia develops and manufactures biological medical devices for complex surgical procedures. This chart shows how investors value its revenue. It reflects their belief in the superiority of its animal-based products over synthetic alternatives and their growing use in surgery.
P/S market segment - Medical instruments
Elutia Inc. (formerly Aziyo Biologics) develops and commercializes regenerative medical products based on biologic materials for cardiac surgery and orthopedics. This chart shows the average rating for medical device manufacturers, providing insight into how the market views Elutia's portfolio of innovative products and their role in improving treatment outcomes.
P/S of the market as a whole
Elutia develops and manufactures biological medical devices to simplify complex surgical procedures. The company's products assist surgeons and improve patient outcomes. This chart shows the premium investors are willing to pay for the revenue of a company offering innovative medical technology solutions.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Elutia Inc.
Elutia develops and manufactures biological medical devices to simplify complex surgical procedures and improve patient outcomes. This chart shows how investors estimate the company's future revenue. It reflects expectations for the acceptance of its products by surgeons and the growing demand for innovative surgical solutions.
%20P%2FS%20Elutia%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Elutia-Inc.&v=1772621346467 "The graph of the company's future (projected) P/S Elutia Inc.")
Future (projected) P/S of the market segment - Medical instruments
Elutia develops and manufactures biological medical devices for surgery. This chart compares the company's estimated future sales with its industry. It reflects the market's appreciation of its innovative products and the extent to which surgeons are adopting them to improve patient outcomes.
%20P%2FS%20market%20segment%20graph%20-%20Medical%20instruments&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Medical-instruments&v=1772621346508 "Future (projected) P/S market segment graph - Medical instruments")
Future (projected) P/S of the market as a whole
Elutia is a company developing and commercializing biological products for complex surgical procedures. This chart illustrates general expectations, and Elutia represents innovation in surgery. The company's growth is an indicator of the demand for more advanced and biocompatible materials to improve surgical outcomes and healing.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772621346563 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Elutia Inc.
Elutia Inc. manufactures biological medical devices for reconstructive surgery. Revenue, shown in this chart, is generated from sales of its products, such as tissue matrices, which are used to strengthen and restore soft tissue in various surgical procedures.
Sales of companies in the market segment - Medical instruments
Elutia Inc. develops and manufactures surgical biomaterials that are completely absorbed by the body over time. Their products are used to strengthen soft tissues. This graph illustrates the growing medical device market, where biocompatible and absorbable materials are increasingly in demand.
Overall market sales
Elutia Inc. produces biological medical devices for surgical procedures. The growth in overall economic revenue, reflected in this chart, contributes to the increase in elective surgery volumes. Hospitals receive better funding, allowing them to use more advanced and effective materials, such as Elutia's products, to improve patient outcomes.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Elutia Inc.
Elutia Inc. is a biomedical company developing biological tissue repair products that are completely absorbed by the body over time. This chart shows analysts' expectations for demand for its regenerative medical devices in surgical practice.
%20sales%20of%20the%20company%20Elutia%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Elutia-Inc.&v=1772621346718 "Schedule of future (projected) sales of the company Elutia Inc.")
Future (projected) sales of companies in the market segment - Medical instruments
Elutia is a regenerative medicine company that develops and manufactures biological implants for plastic and reconstructive surgery. This chart shows forecasts for the medical instrument sector, illustrating the growing demand for advanced solutions that promote tissue healing and restoration.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Medical-instruments&v=1772621346740 "Schedule of future (projected) sales of companies in the market segment - Medical instruments")
Future (projected) sales of the market as a whole
Elutia, a biomedical device company, sees this chart as an indicator of the number of elective surgical procedures. The economic growth reflected here means more people can afford elective surgeries, which directly increases demand for the company's bioresorbable materials and implants.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772621346768 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Elutia Inc.
Elutia develops and manufactures biological medical devices used for tissue healing and regeneration. Profitability depends on the acceptance of its products by surgeons and hospitals. This chart shows how successfully the commercialization of these innovative materials is progressing and how sales revenue is converted into net profit.
Market segment marginality - Medical instruments
Elutia develops and manufactures biological implants for surgery. Their products, such as CanGaroo, are used to stabilize cardiac implants. Profitability in this field depends on product innovation, manufacturing efficiency, and successful collaboration with surgeons and hospitals.
Market marginality as a whole
Elutia is a regenerative medicine company developing biological implants for tissue repair. Based on its overall profitability, Elutia is at the forefront of medical technology. Their profitability depends on the acceptance of their products by surgeons and the demonstration of clinical benefits.
Employees in the company, segment and market as a whole
Number of employees in the company Elutia Inc.
Elutia is a company developing biologics for tissue regeneration. This chart shows the size of its research and manufacturing team. This staffing growth reflects its efforts to manufacture and commercialize its products, which aid in tissue healing and restoration.
Share of the company's employees Elutia Inc. within the market segment - Medical instruments
Elutia Inc. develops and manufactures bioresorbable surgical materials, such as meshes for soft tissue reinforcement. This chart shows the percentage of biomedical engineers and manufacturing personnel in its niche that Elutia attracts. It reflects its expertise in creating innovative medical devices to improve treatment outcomes.
Number of employees in the market segment - Medical instruments
Elutia is a company that develops and manufactures biological medical devices for reconstructive surgery. Its staff includes scientists, engineers, and manufacturing personnel. This chart shows its operational activities. The team's growth may be due to the expansion of production capacity and increased demand for its products from surgeons.
Number of employees in the market as a whole
Elutia Inc. develops and produces biomaterials for surgery. Demand for its products is driven by the number of surgeries performed and the introduction of new medical technologies. This chart shows the overall economy, but for Elutia, demographic trends and healthcare system budgets are more important, as they shape its market.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Elutia Inc. (ELUT)
Elutia is a biomaterials company. This metric reflects the balance between the value of its product patents and the efficiency of its high-tech production. The graph shows how this balance changes as the company grows.
%20of%20the%20company%20Elutia%20Inc.%20(ELUT)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Elutia-Inc.-ELUT&v=1772621346906 "Chart of market capitalization per employee (in thousands of dollars) of the company Elutia Inc. (ELUT)")
Market capitalization per employee (in thousands of dollars) in the market segment - Medical instruments
Elutia Inc. develops and commercializes biological products for complex surgical procedures. In the biomedical sector, this metric reflects the value and uniqueness of its product portfolio. The chart helps understand how effectively the company monetizes its innovations per employee compared to its competitors.
%20by%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Medical-instruments&v=1772621346930 "Market capitalization per employee (in thousands of dollars) by market segment - Medical instruments")
Market capitalization per employee (in thousands of dollars) for the overall market
Elutia is a company that develops and manufactures biomedical products based on biological materials for surgical applications. This is part of the MedTech sector. This chart shows how the market values a business where innovative, patent-protected products and an effective commercial team generate high added value per employee.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772621346961 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Elutia Inc. (ELUT)
Elutia Inc. (ELUT) is a company that develops and manufactures biological implants (meshes) for surgery. It is a niche medical business. This chart shows how successfully the company is commercializing its innovative products. It reflects how much revenue each employee (salesperson, engineer) generates from the sale of these medical devices.
%20Chart%20Elutia%20Inc.%20(ELUT)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Elutia-Inc.-ELUT&v=1772621346992 "Company Profit Per Employee (in thousands of dollars) Chart Elutia Inc. (ELUT)")
Profit per employee (in thousands of dollars) in the market segment - Medical instruments
Elutia (ELUT) (formerly Aziyo Biologics) is a regenerative medicine company that develops and markets biological products for tissue repair (e.g., in cardiac surgery). This chart shows its commercial and manufacturing efficiency. It reflects the company's revenue per employee generated by manufacturing and selling its complex biomaterials.
%20in%20the%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Medical-instruments&v=1772621346999 "Chart of profit per employee (in thousands of dollars) in the market segment - Medical instruments")
Profit per employee (in thousands of dollars) for the market as a whole
Elutia Inc. is a medical device company developing biological implants (for example, for breast reconstruction). It is a MedTech company. This chart shows the company's success in commercializing its products. Its profit per employee depends on the high margins of its innovative implants and the effectiveness of its sales team working with surgeons.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772621347012 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Elutia Inc. (ELUT)
Elutia is a company developing biological products for tissue regeneration. This chart shows how well their products are being adopted in surgical practice. The growth in revenue per employee indicates that the company is effectively expanding its market share by offering innovative solutions for complex medical cases.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Elutia-Inc.-ELUT&v=1772621347027 "Sales chart per company employee Elutia Inc. (ELUT)")
Sales per employee in the market segment - Medical instruments
Elutia is a company that develops and manufactures biological (tissue-based) materials for surgery, similar to TELA Bio. It is a niche MedTech company. This chart shows the average revenue per employee in the sector. It helps assess how productive Elutia's commercial team is in promoting its innovative products to surgeons compared to its competitors.
Sales per employee for the market as a whole
Elutia Inc. (ELUT) (formerly Aziyo Biologics) produces regenerative medical products (based on human tissue) for surgical applications, such as breast reconstruction and wound healing. This chart shows how successful their sales team is in bringing these complex biological products to hospitals.
Short shares by company, segment and market as a whole
Shares shorted by company Elutia Inc. (ELUT)
Elutia (formerly Aziyo Biologics) produces biological implants (matrices) for regenerative medicine. The company is struggling with low profitability and product recalls. This chart shows the number of investors who don't believe in a turnaround. They are betting that the company will fail to achieve profitability or that its products will lose out to the competition.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Elutia-Inc.-ELUT&v=1772621347052 "Short Shares Chart for the Company Elutia Inc. (ELUT)")
Shares shorted by market segment - Medical instruments
Elutia (formerly Aziyo) produces biological implants (matrices) for soft tissue restoration during surgery. This indicator measures bearish sentiment in the sector. It rises when investors anticipate a slowdown in elective surgeries or perceive risks (such as lawsuits related to implants) that could impact the entire industry.
Shares shorted by the overall market
Elutia (formerly Aziyo Biologics) produces biomaterials for surgery. The company is struggling to return to profitability after a restructuring. This chart reflects the general pessimism. When the market is fearful, it doesn't give second chances to companies with a troubled past. Investors fear that ELUT won't be able to fulfill its plan in the economic downturn and are selling off its shares.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Elutia Inc. (ELUT)
Elutia Inc. develops biological tissue regeneration products used in surgery. This indicator tracks how investors view the adoption of its products in hospitals. "Overbought" (above 70) may signal success, while "oversold" (below 30) may reflect concerns about cash flow.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Elutia-Inc.-ELUT&v=1772621347094 "RSI 14 indicator chart for the company's stock Elutia Inc. (ELUT)")
RSI 14 Market Segment - Medical instruments
Elutia (ELUT) (formerly Aziyo) — "biological" repair. They make *"matrices"* (CanGaroo) from *animal* tissue for *strengthening* during *implantation* of cardiac devices. The "Medical instruments" (medtech) sector thrives on R&D. RSI\_14\_Seg shows whether the *entire* sector is "overbought." This helps to differentiate: is ELUT's growth their "niche" or a general "overheating"?
RSI 14 for the overall market
Elutia (ELUT), a medical equipment manufacturer. This chart reflects hospitals' willingness to implement expensive innovations. During periods of euphoria and budget increases, clinics eagerly purchase new technologies. During times of panic and cost-cutting, they may postpone ELUT implementation in favor of cheaper, standard methods.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast ELUT (Elutia Inc.)
Elutia Inc. (formerly Aziyo Biologics) specializes in regenerative medicine, producing biomaterials (CanGaroo) to improve the implantability of cardiac devices. This chart shows the analysts' average 12-month forecast, reflecting their view on how quickly this niche product will be adopted by surgeons.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-ELUT-Elutia-Inc.&v=1772621347214 "A chart showing analyst consensus forecasts for the expected stock price. ELUT (Elutia Inc.)")
The difference between the consensus estimate and the actual stock price ELUT (Elutia Inc.)
Elutia is a biomedical company that produces "biological" implants (based on animal tissue) that serve as a "scaffold" for regenerating a patient's own tissue. This chart shows how the current stock price differs from the "fair" value predicted by analysts. It reflects their faith in this technology.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-ELUT-Elutia-Inc.&v=1772621347239 "A chart showing the difference between the consensus forecast and the actual stock price. ELUT (Elutia Inc.)")
Analyst consensus forecast for stock prices by market segment - Medical instruments
Elutia is a biomedical company. It creates animal tissue "envelopes" (CanGaroo) used to wrap pacemakers to reduce the risk of infection. This chart shows analysts' overall expectations for the medical devices sector. It reflects whether experts believe the market for assistive medical devices will grow.
Analysts' consensus forecast for the overall market share price
Elutia (formerly Aziyo Biologics) is a company specializing in regenerative medicine. They produce tissue-based biomatrices for soft tissue repair and implants. This chart shows the overall market sentiment. For Elutia, which operates in the protective healthcare sector, overall optimism is important for funding, but their growth depends more on the adoption of their products in surgery.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Elutia Inc.
Elutia is a MedTech company specializing in biological implants. They produce surgical meshes and scaffolds made from natural tissues (such as silk) that the body absorbs and replaces with its own over time. This graph summarizes their R&D efforts. It reflects their ability to obtain FDA approval and convince surgeons to use their innovative regenerative materials.
AKIMA Market Segment Index - Medical instruments
Elutia (ELUT) is a medical device company developing and commercializing biomaterials for surgical soft tissue repair, such as CanGaroo biomesh. The chart shows the average index for the segment, helping investors assess how well Elutia competes in the surgical implant market compared to the sector average.
The AKIM Index for the overall market
Elutia (formerly Aziyo) is a medtech company producing biological products for tissue regeneration and medical devices (such as pacemakers). This chart, which reflects the market average, is a backdrop. It helps assess how Elutia, which is recovering from product recalls, compares to overall macroeconomic trends.
